Sebastian Böltz (S Boeltz, Sebastian Boeltz)

ResearcherID Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 6

Top Venues

Nature medicine

Annals of the rheumatic diseases

Rheumatology international

Cell death and differentiation

Friedrich-Alexander-Universitat Erlangen-Nurnberg

Friedrich-Alexander-Universitat Erlangen-Nurnberg (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Friedrich-Alexander-Universitat Erlangen-Nurnberg

Germany

Wissenschaftlicher Mitarbeiter :: University Hospital Erlangen - Institute for Clinical Immunology

King's College London

United Kingdom

Researcher :: Medical & Molecular Genetics - Division of Genetics and Molecular Medicine

Education History

Friedrich-Alexander-Universitat Erlangen-Nurnberg

Germany

MSC :: Molecular Medicine

Friedrich-Alexander-Universitat Erlangen-Nurnberg

Germany

BSC :: Molecular Medicine

Publications

Christina Bergmann, Fabian Müller, Jörg H W Distler, Andrea-Hermina Györfi, Simon Völkl, Michael Aigner, Sascha Kretschmann, Hannah Reimann, Thomas Harrer, Nadine Bayerl, Sebastian Böltz, Andreas Wirsching, Jule Taubmann, Wolf Rösler, Bernd Spriewald, Jochen Wacker, Armin Atzinger, Michael Uder, Torsten Kuwert, Andreas Mackensen, Larissa Valor-Méndez
Treatment of a patient with severe systemic sclerosis (SSc) using CD19-targeted CAR T cells. Annals of the rheumatic diseases (2023)
Andreas Mackensen, Fabian Müller, Dimitrios Mougiakakos, Sebastian Böltz, Artur Wilhelm, Michael Aigner, Simon Völkl, David Simon, Arnd Kleyer, Luis Munoz, Sascha Kretschmann, Soraya Kharboutli, Regina Gary, Hannah Reimann, Wolf Rösler, Stefan Uderhardt, Holger Bang, Martin Herrmann, Arif Bülent Ekici, Christian Buettner, Katharina Marie Habenicht, Thomas H Winkler, Gerhard Krönke, Larissa Valor-Méndez
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus. Nature medicine 28 (10) (2022)
Andreas Mackensen, Fabian Müller, Dimitrios Mougiakakos, Sebastian Böltz, Artur Wilhelm, Michael Aigner, Simon Völkl, David Simon, Arnd Kleyer, Luis Munoz, Sascha Kretschmann, Soraya Kharboutli, Regina Gary, Hannah Reimann, Wolf Rösler, Stefan Uderhardt, Holger Bang, Martin Herrmann, Arif Bülent Ekici, Christian Buettner, Katharina Marie Habenicht, Thomas H Winkler, Gerhard Krönke, Larissa Valor-Méndez
Author Correction: Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus. Nature medicine (2022)
Muehlensiepen Felix, Susanne May, Katharina Hadaschik, Vuillerme Nicolas, Martin Heinze, Manuel Grahammer, Hannah Labinsky, Sebastian Böltz, Jacqueline Detert, Jana Petersen, Gerhard Krönke, Larissa Valor-Méndez, Johannes Knitza
Digitally supported shared decision-making and treat-to-target in rheumatology: a qualitative study embedded in a multicenter randomized controlled trial. Rheumatology international (2022)
Elmar Pieterse, Nils Rother, Cansu Yanginlar, Jelle Gerretsen, Sebastian Böltz, Luis Enrique Munoz, Martin Herrmann, Peter Pickkers, Luuk B Hilbrands, Johan van der Vlag
Cleaved N-terminal histone tails distinguish between NADPH oxidase (NOX)-dependent and NOX-independent pathways of neutrophil extracellular trap formation. Annals of the rheumatic diseases 77 (12) (2018)
R B Birge, Sebastian Böltz, S Kumar, J Carlson, J Wanderley, D Calianese, M Barcinski, R A Brekken, X Huang, J T Hutchins, B Freimark, C Empig, J Mercer, A J Schroit, G Schett, M Herrmann
Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer. Cell death and differentiation 23 (6) (2016)

Sebastian Böltz.css-eqlu8i{font-size:small;padding-left:4px;} (S Boeltz, Sebastian Boeltz)

Publication Activity (10 Years)

Top Topics

Top Venues

Sebastian Böltz (S Boeltz, Sebastian Boeltz)